RxDoctor Payments Data

Devan Partridge, DO

Interventional Pain Medicine · Payson, UTNPI 1427541051

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $4,343 of the $7,062 with a category attached, or 61.5%. 21 manufacturers reported payments, led by Boston Scientific at 34.0% of the total. 2025 is the largest year on record at $2,849, more than ten times the $62 reported in 2019. That places this record below the midpoint for interventional pain medicine clinicians in UT, where the typical reported total is $7,299.

$7,062in general payments, 2019–2025

Across 192 payments — averaging $36.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$2K
  • Saluda Medical Americas, Inc.$2K
  • Medtronic$1K
  • Relievant Medsystems, Inc.$743
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$123
  • Nevro Corp.$83
  • plus $654 from 15 others

What the payments were for

  • Travel & lodging$2,71939%
  • Food & beverage$4,34361%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,062 in reported general payments places this provider in the 45th percentile of 26 interventional pain medicine providers in Utah.

See all interventional pain medicine providers in Utah

Medicare billing

Part B allowed, 2024
$113,506
Medicare patients
88
Services billed
1,166

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen85$2,579
Oxycodone Hcl83$1,846
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen50$920
Morphine Sulfate ErMorphine Sulfate26$903
Gabapentin32$635
Pregabalin47$600
Celecoxib17$479
Methocarbamol22$345
Tramadol Hcl41$337
Tizanidine Hcl26$220
Ibuprofen20$194
Carisoprodol18$182
Memantine Hcl20$177
Meloxicam34$159

Paid to pharmacies, not to this prescriber.

Other interventional pain medicine in Payson

See the full list for Utah

Where these figures come from

Is this you, or does something look wrong? →